542 Drug Delivery II


Description:
Description TBD

Sponsor:
Engineering Fundamentals in Life Science


Chair:
Christopher A. Alabi
Assistant Professor
Cornell University
Chemical and Biomolecular Engineering
120 Olin Hall
Ithaca, NY
14853
Email: caa238@cornell.edu

Co-Chair:
Forrest Kievit
Assistant Professor
University of Nebraska
Biological Systems Engineering
Lincoln, NE
Phone Number: 402-472-2175
Email: fkievit2@unl.edu


Papers:
542a
Transdermal Protein Delivery Via a Choline-Based Deep Eutectic Solvent
Kelly Ibsen, UCSB; Amrita Banerjee, Department of Chemical Engineering, University of California Santa Barbara; Yasunori Iwao, University of Shizuoka; Michael Zakrewsky, University of California Santa Barbara; Samir Mitragotri, University of California, Santa Barbara
542b
Enhanced Delivery to Skin Using Novel Terbinafine Ionic Liquids
Wilmarie Medina-Ramos, Georgia Institute of Technology; Mark R. Prausnitz, Georgia Institute of Technology
542c
Controlled Release of N-Acetylcysteine Positively Affects the Viability, Redox State and Morphology of Oligodendrocyte Progenitor Cells Under Oxidative Stress
Nick P. Murphy, University of Virginia; Kyle Lampe, University of Virginia
542d
Gold Nanocones: A Candidate for Cavitation-Enhanced Drug Delivery
Xiaoqian Su, Nanyang Technological University; James J. Kwan, Nanyang Technological University
542e
Crossing the Blood-Brain Barrier at the Nanoscale: Understanding the Influence of Physical Characteristics
Maksymilian Nowak, University of California, Santa Barbara; Tyler D. Brown, University of California, Santa Barbara; Matthew E. Helgeson, University of California, Santa Barbara; Samir Mitragotri, University of California, Santa Barbara
542f
Targeted Drug Delivery to the Back of the Eye By Hydrogel Pushing in the Suprachoroidal Space
Jae Hwan Jung, Georgia Institute of Technology; Patcharin Desit, Chulalongkorn University; Mark R. Prausnitz, Georgia Institute of Technology
542g
Polymerizable Prodrug Monomers for the Treatment of Serious Intracellular Bacterial Infections
Anthony J. Convertine, University of Washington
Abstract Submissions Closed
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>